Publications by authors named "Vecurkovska I"

Current knowledge of tumor biology offers many "targets" for therapeutic intervention. The molecular basis of many processes that play a role in the pathogenesis of colorectal cancer has been identified. One part of colorectal cancer clinical trials is focused on testing substances in a group of patients with tumors in which the TGF-β signalling pathway is hyperactivated.

View Article and Find Full Text PDF
Article Synopsis
  • Pancreatic cancer is a severe disease with low survival rates, prompting research into non-invasive screening methods like biomarkers to aid early detection.
  • The study followed 46 patients, measuring levels of MMP9 in their serum and tissue, revealing elevated levels at advanced stages of the disease.
  • While MMP9 could be useful for identifying late-stage pancreatic cancer, the study did not find a correlation between MMP9 levels and earlier disease stages, possibly due to the small sample size.
View Article and Find Full Text PDF

Zymography is an electrophoretic method in which proteins are separated in a polyacrylamide gel in the presence of sodium dodecyl sulfate (SDS-PAGE). This method is used for the detection of enzymatic activity and molecular characterization of proteins. In contrast to the standard SDS-PAGE method, a substrate is incorporated into the gel during zymography, which is subsequently cleaved by target proteases.

View Article and Find Full Text PDF

Purpose: The development of sensitive and non-invasive biomarkers for the early detection of CRC and determination of their role in the individual stages of CRC.

Methods: MMP-9 expression in serum and tissue, and BDNF expression in plasma were detected using the ELISA method. MMP-9 and BDNF in the tissue were also determined by immunohistochemical staining.

View Article and Find Full Text PDF

According to data from 2020, Slovakia has long been among the top five countries with the highest incidence rate of colorectal cancer (CRC) worldwide, and the rate is continuing to rise every year. In approximately 80% of CRC cases, allelic loss (loss of heterozygosity, LOH) occurs in the long arm of chromosome 18q. The most important genes that can be silenced by 18q LOH or mutations are small mothers against decapentaplegic homolog (SMAD) 2 and SMAD4, which are intracellular mediators of transforming growth factor (TGF)-β superfamily signals.

View Article and Find Full Text PDF